NERV vs PRU · P/E 2.2, $12.4M cap vs rev $31.19B
Minerva Neurosciences Inc (NERV) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
PRU (PRU) common stock.
NERV does not have a complete income-statement cache yet.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
NERV currently screens at market cap $12.4M and trailing P/E 2.2. PRU currently screens at market cap $0.
Not investment advice. Open the NERV and PRU stock pages for the full models.
Not investment advice.